Organogenesis Holdings slumps after withdrawing 2023 guidance
** Shares of Organogenesis Holdings Inc ORGO.O fall ~34%
to $2.24 before the bell
** ORGO late on Wednesday withdrew its previously announced
2023 guidance due to the uncertainty from the potential impact
of the recently published local coverage determinations on some
of its devices
** Q2 adj net income nearly halved Y/Y after sales fell 3.4%
** Brokerage firm BTIG cuts PT to $4 from $10
** Up to Wednesday's close, stock had risen ~26% this year
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers